Showing results (41-50 of 156) with videos related to
Sort By:
Pageof 16
Journal of Chemical Information and Modeling|September 20, 2012
Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug bindingSerdar Durdagi, Sumukh Deshpande, Henry J Duff, et al.Chemistry & Biodiversity|December 10, 2021
Synthesis and Aldose Reductase Inhibition Effects of Novel N-Benzyl-4-Methoxyaniline DerivativesCetin Bayrak, Gulsah Yildizhan, Namik Kilinc, et al.Bioorganic & Medicinal Chemistry Letters|July 29, 2011
Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitorsReşit Çakmak, Serdar Durdagi, Deniz Ekinci, et al.Current Opinion in Structural Biology|May 15, 2019
Current status of multiscale simulations on GPCRsSerdar Durdagi, Berna Dogan, Ismail Erol, et al.The Journal of Biological Chemistry|February 19, 2017
Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampusAnna N Bukiya, Serdar Durdagi, Sergei Noskov, et al.Journal of Molecular Graphics & Modelling|July 26, 2021
Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening modelTarek Kanan, Duaa Kanan, Ebrahim Jaafar Al Shardoub, et al.Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activitySerdar Durdagi, Manthos G Papadopoulos, Demetris P Papahatjis, et al.Bioorganic Chemistry|August 7, 2021
Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitorsOzge Ozten, Belma Zengin Kurt, Fatih Sonmez, et al.RSC Medicinal Chemistry|August 4, 2022
Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapyFerah Comert Onder, Pinar Siyah, Serdar Durdagi, et al.Journal of Molecular Graphics & Modelling|September 29, 2017
Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivativesBusecan Aksoydan, Isik Kantarcioglu, Ismail Erol, et al.Pageof 16